CVS Health is breaking itself apart. The company said it will split into two publicly traded companies by the first half of 2028. One keeps the CVS Health name and holds the Aetna insurance business and the Caremark drug-benefit manager. The other, called CVS Pharmacy, gets the roughly 9,000 drugstores. Wall Street didn't cheer. The stock fell more than 12% on Wednesday, its worst day since January, even though earnings beat expectations.
This undoes a decade of empire-building. The current CVS was assembled by a nearly $70 billion merger with Aetna in 2018 and the purchase of Caremark for about $21 billion back in 2007. The idea was that owning the insurer, the drug-benefit manager and the drugstores together would cut costs and improve care. It didn't click with customers, who increasingly shopped online, and it drew scrutiny from regulators and lawmakers who don't like healthcare giants that own every link in the chain. A Tennessee law banning that kind of co-ownership takes effect in mid-2028, after the split.
Why the stock fell on good news
Earnings actually beat estimates, yet the stock dropped more than 12%, erasing over $14 billion in value. Investors had doubts. A standalone drugstore company loses the protection of the insurance and benefit units, and must compete in a tough retail-pharmacy business where a big rival went private last year. "Virtually all the feedback is negative, doubting, questioning why now," one analyst wrote, though he thought the reaction was overblown. The company's chief framed it as freeing each business to grow, and said current shareholders will own pieces of both new companies.
We don't hold CVS in our model books. We hold UnitedHealth in 9. We're writing this because the split touches customers, not because we own the stock.
Our read
This is a Consumer Protection story, module M11, with a market lesson attached. Start with the part that touches real people, because most of our readers are CVS customers, not CVS shareholders. When a company that fills your prescriptions, runs your drug plan and may insure you splits apart, the plumbing can change. Which pharmacy is in network, how your mail-order refills work, which plan owns your benefits, all of that can shift over the next couple of years. Nothing changes tomorrow, but it's worth watching the notices you get in 2027 and 2028.
Now the market lesson, which applies even if you've never set foot in a CVS. A breakup is Wall Street's bet that the pieces are worth more apart than together. Sometimes that's right and value gets unlocked. Sometimes, as the 12% drop suggests investors fear here, the pieces are weaker alone. If you own CVS, or any stock announcing a split or spinoff, don't assume the move is automatically good or bad. Ask a simpler question: do you want to own both pieces? Because that's what you'll get. If you'd only want one, plan to sort that out when the split happens. And here's the check for everyone. Read your 2027 open-enrollment and pharmacy notices. This is the kind of corporate change that quietly reroutes where you fill a prescription. If you want help reading how a plan change affects your drug costs, that's fifteen minutes.